These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 33508637

  • 1. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J.
    J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
    [Abstract] [Full Text] [Related]

  • 2. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J.
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [Abstract] [Full Text] [Related]

  • 3. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 4. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.
    PLoS One; 2018 May 01; 13(1):e0190967. PubMed ID: 29324897
    [Abstract] [Full Text] [Related]

  • 5. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Mestecky J, Renfrow MB.
    Semin Immunopathol; 2012 May 01; 34(3):365-82. PubMed ID: 22434325
    [Abstract] [Full Text] [Related]

  • 6. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 7. IgA glycosylation and immune complex formation in IgAN.
    Suzuki H, Novak J.
    Semin Immunopathol; 2021 Oct 30; 43(5):669-678. PubMed ID: 34570260
    [Abstract] [Full Text] [Related]

  • 8. Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries.
    Makita Y, Suzuki H, Nakano D, Yanagawa H, Kano T, Novak J, Nishiyama A, Suzuki Y.
    Nephrol Dial Transplant; 2022 Aug 22; 37(9):1629-1636. PubMed ID: 35746884
    [Abstract] [Full Text] [Related]

  • 9. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    Maixnerova D, Ling C, Hall S, Reily C, Brown R, Neprasova M, Suchanek M, Honsova E, Zima T, Novak J, Tesar V.
    PLoS One; 2019 Aug 22; 14(2):e0212254. PubMed ID: 30794576
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment.
    Knoppova B, Reily C, King RG, Julian BA, Novak J, Green TJ.
    J Clin Med; 2021 Sep 29; 10(19):. PubMed ID: 34640530
    [Abstract] [Full Text] [Related]

  • 11. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 29; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 12. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z, Zhang X, Han W, Yu G, Ying Z, Xu X, Wang M, Zhou X, Lv J, Zhang H.
    Int Immunopharmacol; 2021 Feb 29; 91():107282. PubMed ID: 33370682
    [Abstract] [Full Text] [Related]

  • 13. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 29; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 14. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
    Cambier A, Dossier C, Hogan J, Baudouin V, Maisin A, Couderc A, Kwon T, Gleeson PJ, Monteiro RC.
    Pediatr Nephrol; 2022 Jul 29; 37(7):1597-1603. PubMed ID: 34997322
    [Abstract] [Full Text] [Related]

  • 15. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Jul 29; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 16. Decreased IgA binding levels were accompanied by increased IgG sialylation in IgA nephropathy.
    Liu Y, Chen H, Li H, Wang F, Xing Y, Wu Z, Li W, Jia J, Yan T.
    Clin Nephrol; 2024 Aug 29; 102(2):89-96. PubMed ID: 38856027
    [Abstract] [Full Text] [Related]

  • 17. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb 29; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 18. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 19. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
    Xie X, Liu P, Gao L, Zhang X, Lan P, Bijol V, Lv J, Zhang H, Jin J.
    J Pathol; 2021 Jun 11; 254(2):159-172. PubMed ID: 33660264
    [Abstract] [Full Text] [Related]

  • 20. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 11; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.